This video examines the treatment of patients with low-lying rectal cancer and explores options such as neoadjuvant chemoradiotherapy, which could improve the efficacy of surgery.
In this video, Julio Garcia-Aguilar, MD, PhD, of Memorial Sloan Kettering Cancer Center in New York, discusses the treatment of patients with low-lying rectal cancer.
Garcia-Aguilar also highlights phase II trial that studied neoadjuvant chemoradiotherapy, with the goal of making local excision more effective, as well as the challenges of conducting trials in this type of cancer.
